Marinomed Biotech AG (MARI.VI)

EUR 12.0

(-2.83%)

Operating Expenses Summary of Marinomed Biotech AG

Marinomed Biotech AG's latest annual operating expenses in 2023 was 1.91 Million EUR , down -72.67% from previous year.
Marinomed Biotech AG's latest quarterly operating expenses in 2024 Q1 was 370.4 Thousand EUR , up 180.82% from previous quarter.
Marinomed Biotech AG reported a annual operating expenses of 7.01 Million EUR in annual operating expenses 2022, up 25.93% from previous year.
Marinomed Biotech AG reported a annual operating expenses of 5.56 Million EUR in annual operating expenses 2021, up 6.69% from previous year.
Marinomed Biotech AG reported a quarterly operating expenses of 1.91 Million EUR for 2023 FY, down -72.67% from previous quarter.
Marinomed Biotech AG reported a quarterly operating expenses of 1.93 Million EUR for 2023 Q1, up 47.33% from previous quarter.

Annual Operating Expenses Chart of Marinomed Biotech AG (2023 - 2015)

Historical Annual Operating Expenses of Marinomed Biotech AG (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	1.91 Million EUR	-72.67%
2022	7.01 Million EUR	25.93%
2021	5.56 Million EUR	6.69%
2020	5.22 Million EUR	-9.66%
2019	5.77 Million EUR	15.65%
2018	4.99 Million EUR	114.77%
2017	2.32 Million EUR	34.93%
2016	1.72 Million EUR	-20.47%
2015	2.16 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	370.4 Thousand EUR	180.82%
2023 FY	1.91 Million EUR	-72.67%
2023 Q1	1.93 Million EUR	47.33%
2023 Q2	2.05 Million EUR	6.13%
2023 Q3	1.63 Million EUR	-20.57%
2023 Q4	-458.3 Thousand EUR	-128.11%
2022 Q1	1.84 Million EUR	339.33%
2022 FY	7.01 Million EUR	25.93%
2022 Q4	1.31 Million EUR	-24.78%
2022 Q3	1.74 Million EUR	-17.12%
2022 Q2	2.1 Million EUR	13.84%
2021 Q1	1.85 Million EUR	177.92%
2021 Q3	1.49 Million EUR	-16.71%
2021 Q4	421 Thousand EUR	-71.87%
2021 FY	5.56 Million EUR	6.69%
2021 Q2	1.79 Million EUR	-3.06%
2020 Q1	1.53 Million EUR	33.92%
2020 Q3	1.44 Million EUR	-8.2%
2020 Q4	667.1 Thousand EUR	-53.79%
2020 FY	5.22 Million EUR	-9.66%
2020 Q2	1.57 Million EUR	2.34%
2019 Q2	1.3 Million EUR	-33.77%
2019 Q1	1.96 Million EUR	41.41%
2019 Q4	1.14 Million EUR	-16.06%
2019 FY	5.77 Million EUR	15.65%
2019 Q3	1.36 Million EUR	5.14%
2018 Q1	945.93 Thousand EUR	458.95%
2018 FY	4.99 Million EUR	114.77%
2018 Q4	1.38 Million EUR	-18.74%
2018 Q3	1.7 Million EUR	79.25%
2018 Q2	953.24 Thousand EUR	0.77%
2017 Q4	169.23 Thousand EUR	0.0%
2017 FY	2.32 Million EUR	34.93%
2016 FY	1.72 Million EUR	-20.47%
2015 FY	2.16 Million EUR	0.0%

Peer Operating Expenses Comparison of Marinomed Biotech AG

Name	Operating Expenses	Operating Expenses Difference